PeptiDream Co., Ltd. is a bio-venture company from the University of Tokyo that aims to discover and develop non-standard peptide therapeutics . small During ~ Big To List March 11, 2015 Announcement of press release "Creating regenerated drugs with special peptides" February 09, 2015 Our COO, Keiichi Masaya, will give an invited talk at the international symposium of the 135th Annual Meeting of the Pharmaceutical Society of Japan held in Kobe. January 20, 2015 Reed Patrick, Managing Director of the Company, will give an invited talk at the 7th Asia TIES held in Osaka. December 03, 2014 An interview with Reed Patrick, a director of the Company, was published in Zillion International magazine. September 19, 2014 An article on the potential and future of specialty peptide drugs described by our board member Reed Patrick was published in Innovation in Pharmaceutical Technology (IPT) No. 50. June 13, 2014 We are appearing in TIDES 2014 Interview, where our director, Reed Patrick, gave a keynote speech. April 16, 2014 An interview article with Suga, an outside director of the Company, was posted on the University of Tokyo website ("Maverick Thinking that Produces Advanced Technology"). April 14, 2014 Our Board of Directors, Reed Patrick, will give a keynote speech and an invited talk at TIDES 2014 in Providence, USA. April 01, 2014 Kevin Hudson, Head of Oncology and Life Sciences at AstraZeneca, UK, presented the results of his joint research with us on "a new cancer treatment targeting KRAS" at the Cambridge Cancer Science Symposium. February 27, 2014 An interview article with Kubota, CEO of the Company, was posted on the site "J-Net21" operated by the Organization for Small & Medium Enterprises and Regional Innovation, Japan. February 14, 2014 An interview article with Kubota, CEO of the Company, was published in "TSE Mothers Portal Top Interview Creation". November 28, 2013 Our director, Reed Patrick, will give an invited talk at the Gordon Research Conference in Ventura, California, USA. August 19, 2013 Our director, Reed Patrick, will give an invited talk at the 8th Annual Meeting of the Peptide Therapeutics Symposium held at the Salk Institute for Biological Studies (La Jolla), USA. August 09, 2013 Concluded a non-exclusive patent license agreement with Medical Biology Research Institute Co., Ltd. July 08, 2013 Our president appeared on the TV program "Sage's Choice Leaders". June 11, 2013 Our president appeared in the stock voice "Interview with the top of newly listed companies". April 10, 2013 Concluded a joint research agreement with France's IPSEN for the purpose of new peptide drug discovery. March 24, 2013 "Translational synthesis of a polypeptide having an unnatural skeleton at the N-terminal and its application" is registered as a patent. March 15, 2013 Achieved a milestone (lead compound candidate) in a project with Bristol-Myers Squibb in the United States February 25, 2013 Expanded drug discovery R & D plan with Amgen in the United States. February 15, 2013 Concluded a joint research and development agreement (extension agreement) with Bristol-Myers Squibb in the United States. February 15, 2013 Concluded a joint research and development agreement (extension agreement) with Bristol-Myers Squibb. February 15, 2013 Achieved a milestone (lead compound candidate) in a project with Bristol-Myers Squibb in the United States. February 15, 2013 Our original display technology (PDDS: RAPID display) has been registered as a patent. To List Privacy policy About using the website home news Employment information Contact Us Electronic public notice About us top message Company Profile Corporate philosophy Officer introduction History Business content Alliance Partner Privacy policy About using the website Technical information Flexizyme FIT system RAPID display IR information IR news list Corporate governance Financial information IR library Stock information Stock price information IR calendar FAQ Disclosure policy Disclaimer